Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II.

Guo X, Zhou G, Guo M, Cheung AK, Huang Y, Beddhu S.

Physiol Rep. 2014 Feb 10;2(2):e00230. doi: 10.1002/phy2.230. eCollection 2014 Feb 1.

PMID:
24744899
[PubMed]
Free PMC Article
2.

Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.

Zhou G, Cheung AK, Liu X, Huang Y.

Clin Sci (Lond). 2014 May;126(10):707-20. doi: 10.1042/CS20130223.

PMID:
24195695
[PubMed - indexed for MEDLINE]
3.

A PAI-1 mutant retards diabetic nephropathy in db/db mice through protecting podocytes.

Zhang J, Gu C, Lawrence DA, Cheung AK, Huang Y.

Exp Physiol. 2014 Mar 21. [Epub ahead of print]

PMID:
24443353
[PubMed - as supplied by publisher]
4.

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.

Huang Y, Border WA, Yu L, Zhang J, Lawrence DA, Noble NA.

J Am Soc Nephrol. 2008 Feb;19(2):329-38. doi: 10.1681/ASN.2007040510. Epub 2008 Jan 23.

PMID:
18216319
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.

Sedeek M, Gutsol A, Montezano AC, Burger D, Nguyen Dinh Cat A, Kennedy CR, Burns KD, Cooper ME, Jandeleit-Dahm K, Page P, Szyndralewiez C, Heitz F, Hebert RL, Touyz RM.

Clin Sci (Lond). 2013 Feb;124(3):191-202. doi: 10.1042/CS20120330.

PMID:
22920224
[PubMed - indexed for MEDLINE]
6.

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.

PMID:
10859350
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.

Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.

Diabetes. 2006 May;55(5):1232-42.

PMID:
16644677
[PubMed - indexed for MEDLINE]
Free Article
8.

Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.

Mori J, Patel VB, Ramprasath T, Alrob OA, DesAulniers J, Scholey JW, Lopaschuk GD, Oudit GY.

Am J Physiol Renal Physiol. 2014 Apr 15;306(8):F812-21. doi: 10.1152/ajprenal.00655.2013. Epub 2014 Feb 19.

PMID:
24553436
[PubMed - indexed for MEDLINE]
9.

Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.

Zhang J, Noble NA, Border WA, Huang Y.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F579-88. doi: 10.1152/ajprenal.00548.2009. Epub 2009 Dec 23.

PMID:
20032116
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.

Lin Y, Sun Z.

J Endocrinol. 2011 May;209(2):185-91. doi: 10.1530/JOE-10-0340. Epub 2011 Feb 9.

PMID:
21307121
[PubMed - indexed for MEDLINE]
Free Article
11.

Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.

Cha DR, Zhang X, Zhang Y, Wu J, Su D, Han JY, Fang X, Yu B, Breyer MD, Guan Y.

Diabetes. 2007 Aug;56(8):2036-45. Epub 2007 May 29.

PMID:
17536062
[PubMed - indexed for MEDLINE]
Free Article
12.

Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK.

Circulation. 2008 Apr 29;117(17):2253-61. doi: 10.1161/CIRCULATIONAHA.107.748640. Epub 2008 Apr 21.

PMID:
18427128
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.

Wang LH, Liu JS, Ning WB, Yuan QJ, Zhang FF, Peng ZZ, Lu MM, Luo RN, Fu X, Hu GY, Wang ZH, Tao LJ.

Pharmacology. 2011;88(1-2):88-99. doi: 10.1159/000329419. Epub 2011 Aug 16.

PMID:
21847000
[PubMed - indexed for MEDLINE]
14.

Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.

Hartono SP, Knudsen BE, Lerman LO, Textor SC, Grande JP.

BMC Nephrol. 2014 Apr 4;15:58. doi: 10.1186/1471-2369-15-58.

PMID:
24708836
[PubMed - in process]
Free PMC Article
15.

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

FASEB J. 2000 Mar;14(3):439-47.

PMID:
10698958
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.

Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN.

Am J Pathol. 2001 May;158(5):1653-63.

PMID:
11337363
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].

Ciechanowicz A.

Ann Acad Med Stetin. 1999;Suppl 52:1-93. Review. Polish.

PMID:
10589103
[PubMed - indexed for MEDLINE]
18.

Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.

Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.

Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):571-6.

PMID:
17943690
[PubMed - indexed for MEDLINE]
19.

SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.

Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M.

Am J Physiol Renal Physiol. 2006 Apr;290(4):F813-20. Epub 2005 Nov 8.

PMID:
16278277
[PubMed - indexed for MEDLINE]
Free Article
20.

Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.

Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li YC.

Kidney Int. 2010 Jun;77(11):1000-9. doi: 10.1038/ki.2010.22. Epub 2010 Feb 24.

PMID:
20182412
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk